Saso_test_1

Cellular immunotherapies enable the patient’s immune system to eliminate cancer cells. To implement this process, our team modifies the patient’s immune cells with T-cell receptors (TCR) or chimeric antigen receptors (CAR) that recognize tumor cells. We then re-infuse those cells into the patient’s body where they work as ‘living drugs.’